Viridian Therapeutics Inc. buy BiotechBee
Start price
07.09.22
/
70%
€22.20
Target price
31.05.25
€40.00
Performance (%)
14.41%
End price
05.05.23
€25.40
Summary
This prediction ended on 05.05.23 with a price of €25.40. The prediction had a final performance of 14.41%. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Viridian Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% |
According to BiotechBee what are the pros and cons of Viridian Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year